Cargando…

How low is really low? Comparison of two C‐peptide assays to establish residual C‐peptide production in type 1 diabetes

INTRODUCTION: C‐peptide is an important marker to assess residual insulin production in individuals with type 1 diabetes (T1D). The accuracy and detection limits of C‐peptide assays are important to detect C‐peptide microsecretion and to reliably observe changes over time in these people. We compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Leur, Kitty, Vollenbrock, Charlotte, Dekker, Pim, de Vries, Martine, Birnie, Erwin, Mul, Dick, Wolffenbuttel, Bruce H. R., Groen, Joost, Aanstoot, Henk‐Jan, Boesten, Lianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research: Pathophysiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303196/ https://www.ncbi.nlm.nih.gov/pubmed/34989030 http://dx.doi.org/10.1111/dme.14785

Ejemplares similares

Fasting and meal‐stimulated serum C‐peptide in long‐standing type 1 diabetes mellitus
por: Vollenbrock, Charlotte E., et al.
Publicado: (2022)

Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Wellens, Martine J, et al.
Publicado: (2021)

Which C-peptide assay do you use? Increasing need for describing C-peptide assay performance
por: Dekker, Pim, et al.
Publicado: (2022)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Higher Cord C-Peptide Concentrations Are Associated With Slower Growth Rate in the 1st Year of Life in Girls but Not in Boys
por: Regnault, Nolwenn, et al.
Publicado: (2011)

Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study
por: van der Heyden, Josine C., et al.
Publicado: (2016)

Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes
por: Padmos, Roos C., et al.
Publicado: (2008)

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration
por: Carr, Alice L.J., et al.
Publicado: (2022)

Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
por: Greenbaum, Carla J., et al.
Publicado: (2012)

B-Type Natriuretic Peptide Modulates Ghrelin, Hunger, and Satiety in Healthy Men
por: Vila, Greisa, et al.
Publicado: (2012)

Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes
por: Kuo, Jane Z, et al.
Publicado: (2014)

Rapid Tachyphylaxis of the Glucagon-Like Peptide 1–Induced Deceleration of Gastric Emptying in Humans
por: Nauck, Michael A., et al.
Publicado: (2011)

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes
por: Xu, Ping, et al.
Publicado: (2014)

Protein Engineering Strategies for Sustained Glucagon-Like Peptide-1 Receptor–Dependent Control of Glucose Homeostasis
por: Picha, Kristen M., et al.
Publicado: (2008)

The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
por: Hare, Kristine J., et al.
Publicado: (2010)

Glucagon-Like Peptide 1 Recruits Muscle Microvasculature and Improves Insulin’s Metabolic Action in the Presence of Insulin Resistance
por: Chai, Weidong, et al.
Publicado: (2014)

Type 1 diabetes management: Room for improvement
por: Varkevisser, Rita D. M., et al.
Publicado: (2023)

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2008)

Glucagon-Like Peptide 1 Recruits Microvasculature and Increases Glucose Use in Muscle via a Nitric Oxide–Dependent Mechanism
por: Chai, Weidong, et al.
Publicado: (2012)

Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction
por: Sassoon, Daniel J., et al.
Publicado: (2017)

High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
por: Russo, Isabella, et al.
Publicado: (2012)

Genetic Ablation of cGMP-Dependent Protein Kinase Type I Causes Liver Inflammation and Fasting Hyperglycemia
por: Lutz, Stefan Z., et al.
Publicado: (2011)

Adipose Tissue Dysfunction Signals Progression of Hepatic Steatosis Towards Nonalcoholic Steatohepatitis in C57Bl/6 Mice
por: Duval, Caroline, et al.
Publicado: (2010)

C1q/TNF-Related Protein-3 (CTRP-3) and Pigment Epithelium-Derived Factor (PEDF) Concentrations in Patients With Type 2 Diabetes and Metabolic Syndrome
por: Choi, Kyung Mook, et al.
Publicado: (2012)

Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers
por: Shi, Canxia, et al.
Publicado: (2022)

Differences in lipid and blood pressure measurements between individuals with type 1 diabetes and the general population: a cross-sectional study
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2023)

Effects of Peri-Conception and Pregnancy Glycemic Variability on Pregnancy and Perinatal Complications in Type 1 Diabetes: A Pilot Study
por: Hoek-Hogchem, Riëlle, et al.
Publicado: (2022)

Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in Humans
por: Peter, Andreas, et al.
Publicado: (2010)

Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

An Atypical Form of Diabetes Among Individuals With Low BMI
por: Lontchi-Yimagou, Eric, et al.
Publicado: (2022)

Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes
por: Opazo-Ríos, Lucas, et al.
Publicado: (2020)

Clinical effect of obesity on N‐terminal pro‐B‐type natriuretic peptide cut‐off concentrations for the diagnosis of acute heart failure
por: Kozhuharov, Nikola, et al.
Publicado: (2022)

Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
por: Yeow, Toh Peng, et al.
Publicado: (2017)

GLP-1 Receptor Antagonist Exendin-(9-39) Elevates Fasting Blood Glucose Levels in Congenital Hyperinsulinism Owing to Inactivating Mutations in the ATP-Sensitive K(+) Channel
por: Calabria, Andrew C., et al.
Publicado: (2012)

Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance
por: Kanat, Mustafa, et al.
Publicado: (2012)

Type 1 diabetes and low carbohydrate diets—Defining the degree of nutritional ketosis
por: Ozoran, Hakan, et al.
Publicado: (2023)

Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals
por: Daniele, Giuseppe, et al.
Publicado: (2014)

High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
por: Arnold, Edith, et al.
Publicado: (2010)

Short-Term Caloric Restriction Normalizes Hypothalamic Neuronal Responsiveness to Glucose Ingestion in Patients With Type 2 Diabetes
por: Teeuwisse, Wouter M., et al.
Publicado: (2012)

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors
por: Alatrach, Mariam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qd73ml3e0b2po1u9s15jk7ja57